4//SEC Filing
Faulkingham Dell 4
Accession 0001562180-21-001786
CIK 0001517022other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:08 PM ET
Size
12.8 KB
Accession
0001562180-21-001786
Insider Transaction Report
Form 4
Transactions
- Award
Common Stock
2021-02-26+62,000→ 135,574 total - Sale
Common Stock
2021-03-01$3.40/sh−6,749$22,920→ 128,825 total - Award
Employee Stock Option (Right to buy)
2021-02-26+110,000→ 110,000 totalExercise: $3.46Exp: 2031-02-26→ Common Stock (110,000 underlying)
Footnotes (3)
- [F1]The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.
- [F2]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020.
- [F3]The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.
Issuer
Akebia Therapeutics, Inc.
CIK 0001517022
Entity typeother
Related Parties
1- filerCIK 0001776024
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:08 PM ET
- Size
- 12.8 KB